GB1268835A - New sulphonamides having a blood sugar lowering action - Google Patents
New sulphonamides having a blood sugar lowering actionInfo
- Publication number
- GB1268835A GB1268835A GB30406/69A GB3040669A GB1268835A GB 1268835 A GB1268835 A GB 1268835A GB 30406/69 A GB30406/69 A GB 30406/69A GB 3040669 A GB3040669 A GB 3040669A GB 1268835 A GB1268835 A GB 1268835A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- blood sugar
- lowering action
- sugar lowering
- carbons
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1,268,835. Anti-diabetic sulpha-pyrimidines. SCHERING A.G. 16 June, 1969 [27 June, 1968], No. 30406/69. Heading A5B. [Also in Division C2] Pharmaceutical preparations having antidiabetic action contain as active ingredient compounds I (including salts with bases thereof) wherein R 1 and R 2 are H, halogen or C, to 4 alkyl, alkoxy or alkylmercapto, R 3 is alkyl or cycloalkyl with up to 8 carbons which may be interrupted by at least one oxygen or is alkoxy or cycloalkoxy with up to 8 carbons in which the alkyl or cycloalkyl fragment thereof may be interrupted by at least one oxygen, R 4 is H or C 1 to 4 alkyl, X signifies O, S or NH, Y is C 1 to 4 alkylene and n is 0 to 1 to 4. Bases, e.g. butyl biguanide, for salt formation may also possess a blood sugar-lowering action. Administration may be in the form of tablets, dragees, capsules, pills, suspensions or solutions.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19681770731 DE1770731A1 (en) | 1968-06-27 | 1968-06-27 | New blood sugar lowering sulfonamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1268835A true GB1268835A (en) | 1972-03-29 |
Family
ID=5700618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB30406/69A Expired GB1268835A (en) | 1968-06-27 | 1969-06-16 | New sulphonamides having a blood sugar lowering action |
Country Status (14)
| Country | Link |
|---|---|
| AT (3) | AT291256B (en) |
| BE (1) | BE735287A (en) |
| BR (1) | BR6908777D0 (en) |
| CH (1) | CH518968A (en) |
| DE (1) | DE1770731A1 (en) |
| DK (1) | DK123602B (en) |
| ES (1) | ES368100A1 (en) |
| FR (1) | FR2014300B1 (en) |
| GB (1) | GB1268835A (en) |
| IE (1) | IE33175B1 (en) |
| IL (1) | IL32396A (en) |
| NL (1) | NL6909960A (en) |
| NO (1) | NO124374B (en) |
| SE (1) | SE357365B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003105843A1 (en) * | 2002-06-13 | 2003-12-24 | Kinetek Pharmaceuticals, Inc. | Methods of using isothiazole derivatives to treat cancer or inflammation |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2048906A1 (en) * | 1970-10-06 | 1972-04-13 | Boehringer Mannheim Gmbh, 6800 Mannheim | Blood sugar lowering sulfonylaminopyrimidines and processes for their preparation |
-
1968
- 1968-06-27 DE DE19681770731 patent/DE1770731A1/en active Pending
-
1969
- 1969-05-14 BR BR208777/69A patent/BR6908777D0/en unknown
- 1969-06-03 DK DK300869AA patent/DK123602B/en unknown
- 1969-06-05 CH CH860269A patent/CH518968A/en not_active IP Right Cessation
- 1969-06-06 ES ES368100A patent/ES368100A1/en not_active Expired
- 1969-06-13 IL IL32396A patent/IL32396A/en unknown
- 1969-06-16 GB GB30406/69A patent/GB1268835A/en not_active Expired
- 1969-06-17 AT AT788870A patent/AT291256B/en not_active IP Right Cessation
- 1969-06-17 AT AT788770A patent/AT291255B/en not_active IP Right Cessation
- 1969-06-17 AT AT573169A patent/AT289109B/en not_active IP Right Cessation
- 1969-06-24 SE SE08952/69A patent/SE357365B/xx unknown
- 1969-06-25 IE IE873/69A patent/IE33175B1/en unknown
- 1969-06-26 FR FR696921467A patent/FR2014300B1/fr not_active Expired
- 1969-06-26 NO NO2659/69A patent/NO124374B/no unknown
- 1969-06-27 NL NL6909960A patent/NL6909960A/xx unknown
- 1969-06-27 BE BE735287D patent/BE735287A/xx not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003105843A1 (en) * | 2002-06-13 | 2003-12-24 | Kinetek Pharmaceuticals, Inc. | Methods of using isothiazole derivatives to treat cancer or inflammation |
Also Published As
| Publication number | Publication date |
|---|---|
| IE33175L (en) | 1969-12-27 |
| DK123602B (en) | 1972-07-10 |
| IE33175B1 (en) | 1974-04-03 |
| AT289109B (en) | 1971-04-13 |
| CH518968A (en) | 1972-02-15 |
| BE735287A (en) | 1969-12-29 |
| NL6909960A (en) | 1969-12-30 |
| FR2014300B1 (en) | 1973-01-12 |
| AT291256B (en) | 1971-07-12 |
| IL32396A (en) | 1972-06-28 |
| SE357365B (en) | 1973-06-25 |
| NO124374B (en) | 1972-04-10 |
| IL32396A0 (en) | 1969-08-27 |
| ES368100A1 (en) | 1971-05-01 |
| DE1770731A1 (en) | 1971-11-25 |
| AT291255B (en) | 1971-07-12 |
| BR6908777D0 (en) | 1973-01-23 |
| FR2014300A1 (en) | 1970-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1180766A (en) | 2-Arylamine-1,3-Diazacycloalkenes-(2) and the Preparation Thereof | |
| GB1334327A (en) | Compositions for and method of combating virus infections | |
| GB1256849A (en) | ||
| GB1192768A (en) | N-Substituted 2,3,4,5,-Tetrahydro-1H-3-Benzazepines | |
| GB1268835A (en) | New sulphonamides having a blood sugar lowering action | |
| GB1491503A (en) | Method of preventing and treating thrombosis | |
| GB1352257A (en) | Pyridyltriazoles their preparation and compositions containing them | |
| GB1407856A (en) | Anti-inflammatory thiazole compositions and methods for using same | |
| IE32495B1 (en) | New sulphonamides and process for their manufacture | |
| GB1450801A (en) | Pyridinecarboxamide sulphonylurea hypoglycemic agents | |
| GB1291661A (en) | Sulphonylamino-pyrimidines | |
| GB1195319A (en) | Alkyl Sulfate Salts of 1-(p-Chlorobenzhydryl)-4-Methylhomopiperazines | |
| GB1239567A (en) | ||
| IE37186B1 (en) | Improvements in and relating to the production of benzyl-pyrimidines | |
| GB1187546A (en) | Propanolamine derivatives | |
| GB1160448A (en) | Alkanolamine Derivatives | |
| GB1468079A (en) | Ethanolamine derivatives | |
| GB1262315A (en) | New benzenesulphonamide derivatives, their production ond compositions containing same | |
| GB1313274A (en) | Bicycloalkanecarboxymides and the preparation thereof | |
| GB1377793A (en) | Benzenesulphonamidopyrimidines and process for their manufacture | |
| GB1273399A (en) | Novel formamido-cycloalkane derivatives | |
| ES383340A1 (en) | P-(acetoacetamidoalkyl)benzenesulfonamide derivatives | |
| IE33995B1 (en) | Bornanocarboxamides | |
| ES264827A1 (en) | Novel sulphonamides and a process for the manufacture thereof | |
| GB1342643A (en) | Thioacetanilide derivatives |